• Fed Chair Warsh’s Jackson Hole Hawkish Signals: Can He Deliver?
  • NZD/USD Forecast: Bulls Defend Key Trendline Above 0.5900 – What’s Next?
  • September Fed Rate Hike Fears Overblown: Market Probability Sits at 58%, Not 90%
  • Canadian Dollar Pressured by Dovish BoC Stance and Tariff Uncertainty, TD Securities Says
  • Gold Holds Near $4,450 as Fed Rate-Hike Expectations Keep Buyers Cautious
2026-09-01
Coins by Cryptorank
Bitcoinworld Bitcoinworld
Bitcoinworld Bitcoinworld
  • Crypto News
  • AI News
  • Forex News
  • Sponsored
  • Press Release
  • Events
  • Advertisement
  • More
    • About Us
    • Learn
    • Exclusive Article
    • Reviews
    • Contact Us
    • Privacy Policy
Bitcoinworld
  • Crypto News
  • AI News
  • Forex News
  • Sponsored
  • Press Release
  • Events
  • Advertisement
  • More
    • About Us
    • Learn
    • Exclusive Article
    • Reviews
    • Contact Us
    • Privacy Policy
Skip to content
Home Nanyang Biologics

Nanyang Biologics

The9 Investee Nanyang Biologics (NYB) Advancing Planned Nasdaq Listing for the US$1.5 Billion Business Combination
Press Release

2026-08-11

NYB Obtained Notice of Effectiveness from SEC for Its Form F-4 Registration Statement The9 expects to own 15% to 16% of the combined.

  • by PR Newwire
  • 2026-08-11
  • 0 Comments
Read More

Categories

92

AI News

Crypto News

Bitcoin Treasury Ambition: The Blockchain Group Seeks Staggering €10 Billion

Events

97

Forex News

33

Learn

Press Release

Reviews

Google NewsGoogle News TwitterTwitter LinkedinLinkedin coinmarketcapcoinmarketcap BinanceBinance YouTubeYouTubes

Copyright © 2026 BitcoinWorld | Powered by BitcoinWorld – By BitWorld Media INC